| 0 |
PROPOFOL INFUSION SYNDROME |
626 |
0.8879 |
| 1 |
TRIGEMINO-CARDIAC REFLEX |
58 |
0.7160 |
| 2 |
ANTI FACTOR V ANTIBODY |
20 |
0.7143 |
| 3 |
NEGATIVE PRESSURE PULMONARY OEDEMA |
67 |
0.6837 |
| 4 |
MITOCHONDRIAL DNA MUTATION |
38 |
0.4419 |
| 5 |
NEUROMUSCULAR BLOCK PROLONGED |
143 |
0.3875 |
| 6 |
NEW ONSET REFRACTORY STATUS EPILEPTICUS |
39 |
0.3545 |
| 7 |
DELAYED RECOVERY FROM ANAESTHESIA |
326 |
0.3439 |
| 8 |
AIRWAY PEAK PRESSURE INCREASED |
51 |
0.3355 |
| 9 |
AIRWAY COMPLICATION OF ANAESTHESIA |
88 |
0.3346 |
| 10 |
PSEUDOCHOLINESTERASE DEFICIENCY |
21 |
0.3231 |
| 11 |
POSTOPERATIVE DELIRIUM |
60 |
0.3030 |
| 12 |
MYOGLOBIN URINE PRESENT |
72 |
0.2927 |
| 13 |
ANAESTHETIC COMPLICATION PULMONARY |
26 |
0.2921 |
| 14 |
HYPERTHERMIA MALIGNANT |
416 |
0.2794 |
| 15 |
MECHANICAL VENTILATION COMPLICATION |
41 |
0.2752 |
| 16 |
TRACHEAL DEVIATION |
24 |
0.2727 |
| 17 |
ALLERGY TEST NEGATIVE |
40 |
0.2564 |
| 18 |
UNWANTED AWARENESS DURING ANAESTHESIA |
82 |
0.2500 |
| 19 |
RECURRENCE OF NEUROMUSCULAR BLOCKADE |
42 |
0.2456 |
| 20 |
BURKHOLDERIA TEST POSITIVE |
28 |
0.2258 |
| 21 |
ANAESTHETIC COMPLICATION NEUROLOGICAL |
203 |
0.2241 |
| 22 |
NEUROMUSCULAR BLOCKADE |
46 |
0.2054 |
| 23 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
78 |
0.2053 |
| 24 |
INTRA-ABDOMINAL PRESSURE INCREASED |
32 |
0.2038 |
| 25 |
CSF OLIGOCLONAL BAND PRESENT |
25 |
0.1923 |
| 26 |
CONFUSION POSTOPERATIVE |
24 |
0.1832 |
| 27 |
PROCEDURAL HYPOTENSION |
140 |
0.1645 |
| 28 |
MYOCARDIAL DEPRESSION |
37 |
0.1434 |
| 29 |
PHRENIC NERVE PARALYSIS |
30 |
0.1370 |
| 30 |
PHAEOCHROMOCYTOMA CRISIS |
27 |
0.1274 |
| 31 |
NECROSIS ISCHAEMIC |
56 |
0.1215 |
| 32 |
ANAPHYLACTOID SHOCK |
56 |
0.1191 |
| 33 |
HEPATIC ISCHAEMIA |
36 |
0.1158 |
| 34 |
CARCINOID CRISIS |
24 |
0.1062 |
| 35 |
TRYPTASE INCREASED |
71 |
0.0994 |
| 36 |
SPINAL MUSCULAR ATROPHY |
26 |
0.0963 |
| 37 |
INSPIRATORY CAPACITY DECREASED |
26 |
0.0939 |
| 38 |
POSTOPERATIVE FEVER |
25 |
0.0893 |
| 39 |
ANAPHYLACTIC SHOCK |
2182 |
0.0845 |
| 40 |
ANAESTHETIC COMPLICATION |
221 |
0.0822 |
| 41 |
PCO2 INCREASED |
58 |
0.0815 |
| 42 |
MATERNAL EXPOSURE DURING DELIVERY |
80 |
0.0807 |
| 43 |
TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT |
68 |
0.0802 |
| 44 |
DIABETES INSIPIDUS |
189 |
0.0784 |
| 45 |
RENAL ISCHAEMIA |
40 |
0.0731 |
| 46 |
PO2 INCREASED |
37 |
0.0730 |
| 47 |
ENDOTRACHEAL INTUBATION COMPLICATION |
41 |
0.0695 |
| 48 |
BLOOD GASES ABNORMAL |
37 |
0.0686 |
| 49 |
PRODUCT CONTAMINATION MICROBIAL |
81 |
0.0679 |
| 50 |
INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT |
24 |
0.0661 |
| 51 |
PNEUMATOSIS |
29 |
0.0652 |
| 52 |
HYPOCAPNIA |
27 |
0.0646 |
| 53 |
OPISTHOTONUS |
51 |
0.0641 |
| 54 |
NEONATAL RESPIRATORY DEPRESSION |
21 |
0.0633 |
| 55 |
SKIN TEST POSITIVE |
59 |
0.0632 |
| 56 |
LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
22 |
0.0632 |
| 57 |
LARYNGOSPASM |
167 |
0.0620 |
| 58 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
205 |
0.0618 |
| 59 |
VASOPLEGIA SYNDROME |
99 |
0.0603 |
| 60 |
ELECTROMECHANICAL DISSOCIATION |
48 |
0.0601 |
| 61 |
PROCEDURAL VOMITING |
39 |
0.0600 |
| 62 |
LABILE BLOOD PRESSURE |
71 |
0.0598 |
| 63 |
RESPIRATORY ACIDOSIS |
235 |
0.0597 |
| 64 |
BRONCHOSPASM |
833 |
0.0583 |
| 65 |
DRUG EFFECT PROLONGED |
32 |
0.0580 |
| 66 |
MULTIPLE-DRUG RESISTANCE |
176 |
0.0567 |
| 67 |
MYOGLOBINURIA |
30 |
0.0563 |
| 68 |
OPERATIVE HAEMORRHAGE |
25 |
0.0559 |
| 69 |
ACIDOSIS HYPERCHLORAEMIC |
33 |
0.0556 |
| 70 |
UPPER AIRWAY OBSTRUCTION |
49 |
0.0552 |
| 71 |
PULSELESS ELECTRICAL ACTIVITY |
229 |
0.0547 |
| 72 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
58 |
0.0546 |
| 73 |
BRADYCARDIA FOETAL |
44 |
0.0529 |
| 74 |
CONGESTIVE HEPATOPATHY |
23 |
0.0513 |
| 75 |
ISCHAEMIC CEREBRAL INFARCTION |
59 |
0.0508 |
| 76 |
BRUGADA SYNDROME |
52 |
0.0502 |
| 77 |
RESPIRATORY TRACT INFECTION BACTERIAL |
25 |
0.0502 |
| 78 |
STRESS CARDIOMYOPATHY |
287 |
0.0493 |
| 79 |
MACROGLOSSIA |
27 |
0.0492 |
| 80 |
NON-CARDIOGENIC PULMONARY OEDEMA |
52 |
0.0491 |
| 81 |
STATUS EPILEPTICUS |
548 |
0.0485 |
| 82 |
PROCEDURAL NAUSEA |
39 |
0.0484 |
| 83 |
KOUNIS SYNDROME |
109 |
0.0480 |
| 84 |
HAEMODYNAMIC INSTABILITY |
362 |
0.0475 |
| 85 |
HYPERCAPNIA |
142 |
0.0471 |
| 86 |
HEPATORENAL FAILURE |
28 |
0.0465 |
| 87 |
LOCKED-IN SYNDROME |
21 |
0.0456 |
| 88 |
HYPOVENTILATION |
148 |
0.0454 |
| 89 |
ANTICHOLINERGIC SYNDROME |
71 |
0.0445 |
| 90 |
PNEUMOCOCCAL SEPSIS |
29 |
0.0441 |
| 91 |
PLEOCYTOSIS |
25 |
0.0430 |
| 92 |
DRUG LEVEL CHANGED |
27 |
0.0429 |
| 93 |
VOCAL CORD DYSFUNCTION |
21 |
0.0426 |
| 94 |
AIR EMBOLISM |
20 |
0.0425 |
| 95 |
ABDOMINAL COMPARTMENT SYNDROME |
27 |
0.0424 |
| 96 |
CLONUS |
114 |
0.0416 |
| 97 |
SINUS ARREST |
64 |
0.0408 |
| 98 |
SEIZURE LIKE PHENOMENA |
68 |
0.0400 |
| 99 |
FOETAL EXPOSURE DURING DELIVERY |
27 |
0.0398 |
| 100 |
LARYNGEAL STENOSIS |
23 |
0.0398 |
| 101 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
43 |
0.0391 |
| 102 |
APNOEIC ATTACK |
22 |
0.0390 |
| 103 |
SEROTONIN SYNDROME |
742 |
0.0386 |
| 104 |
RESUSCITATION |
64 |
0.0386 |
| 105 |
CARDIAC OUTPUT DECREASED |
34 |
0.0385 |
| 106 |
ARTERIOSPASM CORONARY |
152 |
0.0378 |
| 107 |
SUBCUTANEOUS EMPHYSEMA |
37 |
0.0377 |
| 108 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
82 |
0.0373 |
| 109 |
NEPHROGENIC DIABETES INSIPIDUS |
42 |
0.0364 |
| 110 |
STRIDOR |
105 |
0.0357 |
| 111 |
RESPIRATORY DEPRESSION |
437 |
0.0356 |
| 112 |
SUSPECTED PRODUCT CONTAMINATION |
36 |
0.0355 |
| 113 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
92 |
0.0351 |
| 114 |
VENTRICULAR FIBRILLATION |
379 |
0.0341 |
| 115 |
TONIC CLONIC MOVEMENTS |
44 |
0.0338 |
| 116 |
BLOOD PH DECREASED |
57 |
0.0333 |
| 117 |
INTESTINAL PSEUDO-OBSTRUCTION |
29 |
0.0330 |
| 118 |
ANAPHYLACTIC REACTION |
1762 |
0.0319 |
| 119 |
SEDATION COMPLICATION |
81 |
0.0317 |
| 120 |
CLONIC CONVULSION |
23 |
0.0314 |
| 121 |
CIRCULATORY COLLAPSE |
529 |
0.0310 |
| 122 |
INTESTINAL ISCHAEMIA |
171 |
0.0310 |
| 123 |
HYPERTRIGLYCERIDAEMIA |
181 |
0.0309 |
| 124 |
SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA |
25 |
0.0304 |
| 125 |
MYOCLONIC EPILEPSY |
46 |
0.0303 |
| 126 |
APNOEA |
236 |
0.0303 |
| 127 |
BLOOD PRESSURE IMMEASURABLE |
46 |
0.0300 |
| 128 |
TYPE I HYPERSENSITIVITY |
105 |
0.0298 |
| 129 |
ELECTROENCEPHALOGRAM ABNORMAL |
93 |
0.0294 |
| 130 |
PCO2 DECREASED |
28 |
0.0290 |
| 131 |
APGAR SCORE LOW |
37 |
0.0287 |
| 132 |
BRADYARRHYTHMIA |
46 |
0.0280 |
| 133 |
HEPATORENAL SYNDROME |
47 |
0.0278 |
| 134 |
ENDOTRACHEAL INTUBATION |
76 |
0.0271 |
| 135 |
MYOCLONUS |
323 |
0.0271 |
| 136 |
TORSADE DE POINTES |
210 |
0.0267 |
| 137 |
PERFORATION |
21 |
0.0261 |
| 138 |
PULSE ABSENT |
124 |
0.0260 |
| 139 |
ANAPHYLACTOID REACTION |
107 |
0.0260 |
| 140 |
NODAL RHYTHM |
36 |
0.0246 |
| 141 |
CONTINUOUS HAEMODIAFILTRATION |
24 |
0.0245 |
| 142 |
VENTRICULAR TACHYCARDIA |
405 |
0.0245 |
| 143 |
ACUTE LUNG INJURY |
29 |
0.0245 |
| 144 |
PRINZMETAL ANGINA |
24 |
0.0241 |
| 145 |
MYOCARDIAL INJURY |
27 |
0.0240 |
| 146 |
CARDIOVASCULAR INSUFFICIENCY |
39 |
0.0239 |
| 147 |
GENERALISED ERYTHEMA |
136 |
0.0239 |
| 148 |
PRODUCT CONTAMINATION |
85 |
0.0239 |
| 149 |
PROCEDURAL COMPLICATION |
183 |
0.0238 |
| 150 |
METHAEMOGLOBINAEMIA |
55 |
0.0237 |
| 151 |
PUPILS UNEQUAL |
27 |
0.0236 |
| 152 |
VENTRICULAR ARRHYTHMIA |
86 |
0.0235 |
| 153 |
BRAIN HERNIATION |
70 |
0.0234 |
| 154 |
OCULOGYRIC CRISIS |
50 |
0.0233 |
| 155 |
HYPERREFLEXIA |
81 |
0.0232 |
| 156 |
VENTRICULAR HYPOKINESIA |
74 |
0.0230 |
| 157 |
GAZE PALSY |
39 |
0.0229 |
| 158 |
BRADYCARDIA |
1212 |
0.0228 |
| 159 |
BLOOD LACTIC ACID INCREASED |
119 |
0.0226 |
| 160 |
PARTIAL SEIZURES |
118 |
0.0225 |
| 161 |
CARDIAC ARREST |
1851 |
0.0224 |
| 162 |
RHABDOMYOLYSIS |
932 |
0.0223 |
| 163 |
MYOGLOBIN BLOOD INCREASED |
34 |
0.0222 |
| 164 |
HEPATIC CONGESTION |
21 |
0.0222 |
| 165 |
MECHANICAL VENTILATION |
42 |
0.0221 |
| 166 |
ACUTE PULMONARY OEDEMA |
124 |
0.0221 |
| 167 |
HYPERLACTACIDAEMIA |
59 |
0.0220 |
| 168 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
64 |
0.0219 |
| 169 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
112 |
0.0218 |
| 170 |
SYSTOLIC DYSFUNCTION |
23 |
0.0218 |
| 171 |
PO2 DECREASED |
25 |
0.0217 |
| 172 |
BRAIN DEATH |
67 |
0.0217 |
| 173 |
BLOOD BICARBONATE DECREASED |
41 |
0.0216 |
| 174 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
82 |
0.0214 |
| 175 |
AMYLASE INCREASED |
77 |
0.0208 |
| 176 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
162 |
0.0208 |
| 177 |
TOXIC ENCEPHALOPATHY |
105 |
0.0207 |
| 178 |
SUPERINFECTION |
31 |
0.0207 |
| 179 |
HYPORESPONSIVE TO STIMULI |
24 |
0.0204 |
| 180 |
MULTI-ORGAN FAILURE |
353 |
0.0204 |
| 181 |
METABOLIC ACIDOSIS |
648 |
0.0202 |
| 182 |
THYROTOXIC CRISIS |
23 |
0.0202 |
| 183 |
PULMONARY ALVEOLAR HAEMORRHAGE |
112 |
0.0199 |
| 184 |
ATRIOVENTRICULAR BLOCK COMPLETE |
133 |
0.0199 |
| 185 |
AREFLEXIA |
53 |
0.0198 |
| 186 |
OLIGURIA |
123 |
0.0198 |
| 187 |
NEUROMYOPATHY |
21 |
0.0197 |
| 188 |
INCREASED BRONCHIAL SECRETION |
50 |
0.0195 |
| 189 |
HYPOXIA |
687 |
0.0195 |
| 190 |
POST PROCEDURAL COMPLICATION |
373 |
0.0194 |
| 191 |
TACHYARRHYTHMIA |
48 |
0.0192 |
| 192 |
PILOERECTION |
21 |
0.0192 |
| 193 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
33 |
0.0190 |
| 194 |
LONG QT SYNDROME |
45 |
0.0187 |
| 195 |
GENE MUTATION |
37 |
0.0187 |
| 196 |
RESPIRATORY ALKALOSIS |
30 |
0.0184 |
| 197 |
ACIDOSIS |
141 |
0.0184 |
| 198 |
SHOCK |
424 |
0.0184 |
| 199 |
TORTICOLLIS |
39 |
0.0184 |
| 200 |
TOXIC EPIDERMAL NECROLYSIS |
279 |
0.0184 |
| 201 |
HYPOVOLAEMIA |
107 |
0.0183 |
| 202 |
NEUROLOGICAL DECOMPENSATION |
42 |
0.0181 |
| 203 |
VENTRICULAR DYSFUNCTION |
47 |
0.0181 |
| 204 |
PRIAPISM |
61 |
0.0177 |
| 205 |
QUADRIPARESIS |
29 |
0.0175 |
| 206 |
HYPERNATRAEMIA |
87 |
0.0174 |
| 207 |
PUPIL FIXED |
30 |
0.0173 |
| 208 |
LARYNGEAL OEDEMA |
106 |
0.0172 |
| 209 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
25 |
0.0171 |
| 210 |
BRAIN OEDEMA |
216 |
0.0171 |
| 211 |
MIXED LIVER INJURY |
51 |
0.0169 |
| 212 |
SHOCK HAEMORRHAGIC |
137 |
0.0168 |
| 213 |
EXTRAVASATION |
69 |
0.0168 |
| 214 |
ENCEPHALITIS AUTOIMMUNE |
22 |
0.0167 |
| 215 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
21 |
0.0164 |
| 216 |
HYPERTHERMIA |
125 |
0.0164 |
| 217 |
OXYGEN SATURATION ABNORMAL |
46 |
0.0162 |
| 218 |
PUPILLARY REFLEX IMPAIRED |
30 |
0.0162 |
| 219 |
ISCHAEMIC HEPATITIS |
22 |
0.0161 |
| 220 |
PSEUDOMONAL SEPSIS |
28 |
0.0160 |
| 221 |
CONVERSION DISORDER |
31 |
0.0160 |
| 222 |
ATELECTASIS |
154 |
0.0159 |
| 223 |
ELECTROCARDIOGRAM T WAVE INVERSION |
35 |
0.0158 |
| 224 |
TACHYPNOEA |
213 |
0.0157 |
| 225 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
277 |
0.0156 |
| 226 |
SINUS BRADYCARDIA |
151 |
0.0156 |
| 227 |
CARDIOGENIC SHOCK |
223 |
0.0155 |
| 228 |
TROPONIN INCREASED |
118 |
0.0155 |
| 229 |
PNEUMOMEDIASTINUM |
28 |
0.0155 |
| 230 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
47 |
0.0155 |
| 231 |
SINUS TACHYCARDIA |
219 |
0.0154 |
| 232 |
SUSPECTED PRODUCT QUALITY ISSUE |
28 |
0.0153 |
| 233 |
SPUTUM INCREASED |
33 |
0.0152 |
| 234 |
HEPATITIS FULMINANT |
45 |
0.0152 |
| 235 |
INTRA-ABDOMINAL HAEMORRHAGE |
36 |
0.0151 |
| 236 |
SUPRAVENTRICULAR EXTRASYSTOLES |
51 |
0.0151 |
| 237 |
CHOREA |
26 |
0.0151 |
| 238 |
VENTRICULAR EXTRASYSTOLES |
156 |
0.0150 |
| 239 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
423 |
0.0149 |
| 240 |
HYPOTENSION |
2992 |
0.0149 |
| 241 |
FOETAL DEATH |
77 |
0.0148 |
| 242 |
HEPATOCELLULAR DAMAGE |
33 |
0.0146 |
| 243 |
OXYGEN SATURATION DECREASED |
820 |
0.0146 |
| 244 |
COAGULOPATHY |
242 |
0.0145 |
| 245 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
417 |
0.0145 |
| 246 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
138 |
0.0144 |
| 247 |
RASH MORBILLIFORM |
40 |
0.0144 |
| 248 |
MUSCLE RIGIDITY |
172 |
0.0144 |
| 249 |
PANCREATITIS NECROTISING |
33 |
0.0143 |
| 250 |
LUNG CONSOLIDATION |
40 |
0.0143 |
| 251 |
HYPERAMMONAEMIA |
71 |
0.0142 |
| 252 |
PNEUMONIA STAPHYLOCOCCAL |
28 |
0.0142 |
| 253 |
CHRONIC GASTRITIS |
32 |
0.0142 |
| 254 |
CYTOLYTIC HEPATITIS |
47 |
0.0141 |
| 255 |
LEFT VENTRICULAR DYSFUNCTION |
94 |
0.0140 |
| 256 |
TACHYCARDIA |
1234 |
0.0139 |
| 257 |
PARADOXICAL DRUG REACTION |
51 |
0.0138 |
| 258 |
HAEMOTHORAX |
40 |
0.0138 |
| 259 |
GENERALISED TONIC-CLONIC SEIZURE |
228 |
0.0138 |
| 260 |
CHEST X-RAY ABNORMAL |
42 |
0.0137 |
| 261 |
HEPATITIS ACUTE |
89 |
0.0137 |
| 262 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
67 |
0.0136 |
| 263 |
DISSEMINATED INTRAVASCULAR COAGULATION |
191 |
0.0136 |
| 264 |
NYSTAGMUS |
72 |
0.0136 |
| 265 |
PARAPLEGIA |
39 |
0.0135 |
| 266 |
BRONCHIAL DISORDER |
21 |
0.0135 |
| 267 |
METABOLIC SYNDROME |
22 |
0.0134 |
| 268 |
RESPIRATORY RATE DECREASED |
42 |
0.0134 |
| 269 |
NEPHROGENIC ANAEMIA |
61 |
0.0132 |
| 270 |
MYDRIASIS |
162 |
0.0126 |
| 271 |
ATRIOVENTRICULAR BLOCK |
97 |
0.0125 |
| 272 |
NEUROLEPTIC MALIGNANT SYNDROME |
148 |
0.0125 |
| 273 |
FEAR OF DEATH |
28 |
0.0124 |
| 274 |
HAEMODIALYSIS |
104 |
0.0124 |
| 275 |
DYSTONIA |
240 |
0.0124 |
| 276 |
BLOOD PRESSURE SYSTOLIC DECREASED |
56 |
0.0123 |
| 277 |
RESPIRATORY ARREST |
339 |
0.0123 |
| 278 |
PROCEDURAL HAEMORRHAGE |
48 |
0.0123 |
| 279 |
BLOOD AMYLASE INCREASED |
21 |
0.0123 |
| 280 |
UNRESPONSIVE TO STIMULI |
315 |
0.0122 |
| 281 |
ABDOMINAL RIGIDITY |
33 |
0.0122 |
| 282 |
COMA SCALE ABNORMAL |
35 |
0.0121 |
| 283 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
310 |
0.0120 |
| 284 |
HYPERPARATHYROIDISM SECONDARY |
30 |
0.0120 |
| 285 |
PERIORBITAL OEDEMA |
62 |
0.0119 |
| 286 |
LEFT VENTRICULAR HYPERTROPHY |
51 |
0.0119 |
| 287 |
SUPRAVENTRICULAR TACHYCARDIA |
114 |
0.0119 |
| 288 |
DEAFNESS NEUROSENSORY |
39 |
0.0118 |
| 289 |
PATENT DUCTUS ARTERIOSUS |
47 |
0.0118 |
| 290 |
ACUTE HEPATIC FAILURE |
160 |
0.0117 |
| 291 |
HEPATOCELLULAR INJURY |
166 |
0.0117 |
| 292 |
KLEBSIELLA INFECTION |
59 |
0.0117 |
| 293 |
QUADRIPLEGIA |
24 |
0.0116 |
| 294 |
HYPOTHERMIA |
117 |
0.0115 |
| 295 |
ANURIA |
99 |
0.0115 |
| 296 |
CYANOSIS |
180 |
0.0114 |
| 297 |
NECROTISING FASCIITIS |
40 |
0.0113 |
| 298 |
ACCIDENTAL DEATH |
21 |
0.0113 |
| 299 |
RENAL TUBULAR NECROSIS |
111 |
0.0113 |
| 300 |
ATRIOVENTRICULAR BLOCK FIRST DEGREE |
49 |
0.0113 |
| 301 |
HYPERKALAEMIA |
395 |
0.0113 |
| 302 |
BRADYPNOEA |
30 |
0.0111 |
| 303 |
CELL DEATH |
22 |
0.0111 |
| 304 |
ACUTE RESPIRATORY FAILURE |
212 |
0.0110 |
| 305 |
POLYURIA |
90 |
0.0110 |
| 306 |
ENCEPHALOPATHY |
269 |
0.0109 |
| 307 |
HEPATIC CYTOLYSIS |
139 |
0.0109 |
| 308 |
HYPOVOLAEMIC SHOCK |
52 |
0.0108 |
| 309 |
TONGUE OEDEMA |
41 |
0.0107 |
| 310 |
POTENTIATING DRUG INTERACTION |
36 |
0.0107 |
| 311 |
VASODILATATION |
27 |
0.0107 |
| 312 |
ESCHERICHIA BACTERAEMIA |
25 |
0.0106 |
| 313 |
BUNDLE BRANCH BLOCK LEFT |
45 |
0.0106 |
| 314 |
PREMATURE DELIVERY |
168 |
0.0105 |
| 315 |
BUNDLE BRANCH BLOCK RIGHT |
48 |
0.0104 |
| 316 |
CARDIO-RESPIRATORY ARREST |
437 |
0.0104 |
| 317 |
BRAIN INJURY |
104 |
0.0104 |
| 318 |
RESPIRATORY FAILURE |
752 |
0.0103 |
| 319 |
CEREBRAL ISCHAEMIA |
53 |
0.0103 |
| 320 |
DISTRIBUTIVE SHOCK |
23 |
0.0101 |
| 321 |
ELECTROCARDIOGRAM QT PROLONGED |
365 |
0.0101 |
| 322 |
FEAR |
272 |
0.0101 |
| 323 |
DRUG INTERACTION |
1583 |
0.0100 |
| 324 |
COMPARTMENT SYNDROME |
26 |
0.0100 |
| 325 |
STAPHYLOCOCCUS TEST POSITIVE |
21 |
0.0100 |
| 326 |
STUPOR |
32 |
0.0100 |
| 327 |
BILIRUBIN CONJUGATED INCREASED |
23 |
0.0098 |
| 328 |
LANGUAGE DISORDER |
21 |
0.0097 |
| 329 |
PREMATURE BABY |
292 |
0.0097 |
| 330 |
LOW BIRTH WEIGHT BABY |
77 |
0.0097 |
| 331 |
TRISMUS |
50 |
0.0097 |
| 332 |
RENAL FAILURE ACUTE |
410 |
0.0097 |
| 333 |
NORMAL NEWBORN |
52 |
0.0096 |
| 334 |
HYPERBILIRUBINAEMIA |
99 |
0.0095 |
| 335 |
INTRACRANIAL PRESSURE INCREASED |
53 |
0.0095 |
| 336 |
BLOOD PRESSURE DECREASED |
630 |
0.0095 |
| 337 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
48 |
0.0095 |
| 338 |
OBSTRUCTIVE AIRWAYS DISORDER |
105 |
0.0094 |
| 339 |
DRUG LEVEL BELOW THERAPEUTIC |
52 |
0.0094 |
| 340 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
25 |
0.0094 |
| 341 |
INCORRECT DRUG ADMINISTRATION RATE |
40 |
0.0094 |
| 342 |
HEPATITIS C |
113 |
0.0094 |
| 343 |
RASH MACULO-PAPULAR |
208 |
0.0093 |
| 344 |
METABOLIC ENCEPHALOPATHY |
28 |
0.0093 |
| 345 |
ANTINUCLEAR ANTIBODY POSITIVE |
30 |
0.0092 |
| 346 |
ASPIRATION |
101 |
0.0092 |
| 347 |
HEPATITIS TOXIC |
24 |
0.0092 |
| 348 |
MYOCARDIAL ISCHAEMIA |
104 |
0.0091 |
| 349 |
EOSINOPHILIA |
160 |
0.0091 |
| 350 |
LEUKOCYTOSIS |
165 |
0.0091 |
| 351 |
POST PROCEDURAL HAEMORRHAGE |
106 |
0.0091 |
| 352 |
HISTIOCYTOSIS HAEMATOPHAGIC |
27 |
0.0091 |
| 353 |
CLOSTRIDIUM TEST POSITIVE |
20 |
0.0091 |
| 354 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
357 |
0.0090 |
| 355 |
SEPTIC SHOCK |
390 |
0.0090 |
| 356 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
142 |
0.0090 |
| 357 |
PNEUMOTHORAX |
141 |
0.0089 |
| 358 |
DELIRIUM |
306 |
0.0088 |
| 359 |
BLOOD PHOSPHORUS INCREASED |
24 |
0.0088 |
| 360 |
RESPIRATORY DISTRESS |
240 |
0.0087 |
| 361 |
GRAND MAL CONVULSION |
80 |
0.0087 |
| 362 |
HYPOTONIA |
86 |
0.0086 |
| 363 |
METABOLIC DISORDER |
50 |
0.0086 |
| 364 |
THROMBOPHLEBITIS |
30 |
0.0085 |
| 365 |
WEIGHT BEARING DIFFICULTY |
23 |
0.0085 |
| 366 |
DIASTOLIC DYSFUNCTION |
26 |
0.0084 |
| 367 |
HYPERTONIA |
48 |
0.0084 |
| 368 |
PNEUMONIA ASPIRATION |
208 |
0.0083 |
| 369 |
LIP OEDEMA |
35 |
0.0083 |
| 370 |
HEPATIC FAILURE |
248 |
0.0082 |
| 371 |
CARDIOPULMONARY FAILURE |
32 |
0.0082 |
| 372 |
HYPERTENSIVE CRISIS |
91 |
0.0082 |
| 373 |
ILEUS |
101 |
0.0081 |
| 374 |
RENAL INJURY |
241 |
0.0081 |
| 375 |
CARDIAC FAILURE ACUTE |
54 |
0.0081 |
| 376 |
CARDIAC DYSFUNCTION |
30 |
0.0081 |
| 377 |
PULMONARY OEDEMA |
361 |
0.0081 |
| 378 |
MOTOR DYSFUNCTION |
82 |
0.0080 |
| 379 |
CHOLESTASIS |
153 |
0.0080 |
| 380 |
HEPATIC NECROSIS |
30 |
0.0080 |
| 381 |
FACE OEDEMA |
134 |
0.0079 |
| 382 |
PERIPHERAL ISCHAEMIA |
32 |
0.0078 |
| 383 |
LUNG INFILTRATION |
69 |
0.0078 |
| 384 |
ENCEPHALITIS |
54 |
0.0078 |
| 385 |
ELECTROCARDIOGRAM ABNORMAL |
61 |
0.0078 |
| 386 |
HYPERVENTILATION |
45 |
0.0078 |
| 387 |
SCOLIOSIS |
48 |
0.0077 |
| 388 |
LACTIC ACIDOSIS |
249 |
0.0077 |
| 389 |
URINE OUTPUT DECREASED |
67 |
0.0077 |
| 390 |
CATATONIA |
40 |
0.0076 |
| 391 |
ANHEDONIA |
200 |
0.0076 |
| 392 |
HYPOALBUMINAEMIA |
59 |
0.0076 |
| 393 |
CONJUNCTIVAL HYPERAEMIA |
27 |
0.0076 |
| 394 |
AGITATION |
554 |
0.0075 |
| 395 |
DRUG USE DISORDER |
63 |
0.0075 |
| 396 |
PANCREATITIS ACUTE |
168 |
0.0075 |
| 397 |
EXTRASYSTOLES |
52 |
0.0074 |
| 398 |
CEREBRAL HAEMATOMA |
25 |
0.0074 |
| 399 |
HYPERTRANSAMINASAEMIA |
51 |
0.0073 |
| 400 |
BLOOD ALBUMIN DECREASED |
58 |
0.0073 |
| 401 |
PARALYSIS |
104 |
0.0073 |
| 402 |
RALES |
42 |
0.0072 |
| 403 |
COMA |
344 |
0.0072 |
| 404 |
HYPOPNOEA |
25 |
0.0072 |
| 405 |
ORGAN FAILURE |
29 |
0.0072 |
| 406 |
NECROSIS |
40 |
0.0072 |
| 407 |
HEPATITIS |
183 |
0.0071 |
| 408 |
PSEUDOMONAS INFECTION |
61 |
0.0071 |
| 409 |
HYPERPYREXIA |
30 |
0.0071 |
| 410 |
HYPERVOLAEMIA |
35 |
0.0071 |
| 411 |
DISEASE COMPLICATION |
32 |
0.0070 |
| 412 |
EMBOLIC STROKE |
24 |
0.0068 |
| 413 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
372 |
0.0068 |
| 414 |
ACUTE KIDNEY INJURY |
1024 |
0.0067 |
| 415 |
HEPATITIS CHOLESTATIC |
40 |
0.0066 |
| 416 |
ALTERED STATE OF CONSCIOUSNESS |
143 |
0.0066 |
| 417 |
EYE MOVEMENT DISORDER |
45 |
0.0066 |
| 418 |
STEVENS-JOHNSON SYNDROME |
146 |
0.0066 |
| 419 |
BLOOD CALCIUM DECREASED |
73 |
0.0065 |
| 420 |
LEUKOENCEPHALOPATHY |
24 |
0.0064 |
| 421 |
COVID-19 PNEUMONIA |
76 |
0.0064 |
| 422 |
BLOOD POTASSIUM INCREASED |
104 |
0.0064 |
| 423 |
DUODENAL ULCER |
45 |
0.0064 |
| 424 |
THROMBOTIC MICROANGIOPATHY |
62 |
0.0064 |
| 425 |
DERMATITIS BULLOUS |
46 |
0.0063 |
| 426 |
ANGIOEDEMA |
276 |
0.0062 |
| 427 |
MONOPLEGIA |
27 |
0.0062 |
| 428 |
DYSKINESIA |
252 |
0.0062 |
| 429 |
SALIVARY HYPERSECRETION |
62 |
0.0062 |
| 430 |
FIBRIN D DIMER INCREASED |
22 |
0.0062 |
| 431 |
PROTHROMBIN TIME PROLONGED |
37 |
0.0062 |
| 432 |
CARDIOMEGALY |
76 |
0.0062 |
| 433 |
RENAL IMPAIRMENT |
519 |
0.0062 |
| 434 |
RENAL FAILURE |
820 |
0.0062 |
| 435 |
ALANINE AMINOTRANSFERASE INCREASED |
376 |
0.0061 |
| 436 |
ANGIOPATHY |
34 |
0.0061 |
| 437 |
TOXIC SKIN ERUPTION |
61 |
0.0061 |
| 438 |
INJURY |
424 |
0.0060 |
| 439 |
HYPERLIPIDAEMIA |
72 |
0.0060 |
| 440 |
IRON DEFICIENCY |
27 |
0.0060 |
| 441 |
MUSCLE CONTRACTIONS INVOLUNTARY |
21 |
0.0060 |
| 442 |
TRICUSPID VALVE INCOMPETENCE |
47 |
0.0059 |
| 443 |
SUBARACHNOID HAEMORRHAGE |
60 |
0.0059 |
| 444 |
CARDIOTOXICITY |
52 |
0.0058 |
| 445 |
HYPOPHOSPHATAEMIA |
43 |
0.0058 |
| 446 |
BLOOD MAGNESIUM DECREASED |
50 |
0.0058 |
| 447 |
FOETAL EXPOSURE DURING PREGNANCY |
470 |
0.0058 |
| 448 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
35 |
0.0057 |
| 449 |
PULMONARY HAEMORRHAGE |
45 |
0.0057 |
| 450 |
CREATININE RENAL CLEARANCE DECREASED |
23 |
0.0057 |
| 451 |
BLOOD BILIRUBIN INCREASED |
154 |
0.0057 |
| 452 |
SPINAL OSTEOARTHRITIS |
50 |
0.0057 |
| 453 |
BREATH SOUNDS ABNORMAL |
28 |
0.0057 |
| 454 |
MITRAL VALVE INCOMPETENCE |
64 |
0.0056 |
| 455 |
INFUSION SITE EXTRAVASATION |
35 |
0.0056 |
| 456 |
FOETAL GROWTH RESTRICTION |
34 |
0.0056 |
| 457 |
ARTERIOSCLEROSIS CORONARY ARTERY |
37 |
0.0056 |
| 458 |
NO THERAPEUTIC RESPONSE |
68 |
0.0056 |
| 459 |
TRANSAMINASES INCREASED |
124 |
0.0056 |
| 460 |
MALABSORPTION |
29 |
0.0055 |
| 461 |
BLOOD TRIGLYCERIDES INCREASED |
98 |
0.0055 |
| 462 |
NEUROTOXICITY |
97 |
0.0055 |
| 463 |
AMMONIA INCREASED |
28 |
0.0055 |
| 464 |
CARDIAC TAMPONADE |
26 |
0.0055 |
| 465 |
ASPARTATE AMINOTRANSFERASE INCREASED |
290 |
0.0055 |
| 466 |
MATERNAL EXPOSURE DURING PREGNANCY |
483 |
0.0054 |
| 467 |
GUILLAIN-BARRE SYNDROME |
26 |
0.0054 |
| 468 |
DEMYELINATION |
22 |
0.0054 |
| 469 |
PERFORMANCE STATUS DECREASED |
25 |
0.0054 |
| 470 |
DRUG TOXICITY |
72 |
0.0053 |
| 471 |
CEREBRAL ATROPHY |
21 |
0.0053 |
| 472 |
AZOTAEMIA |
21 |
0.0053 |
| 473 |
MENTAL STATUS CHANGES |
145 |
0.0052 |
| 474 |
CARDIOMYOPATHY |
77 |
0.0052 |
| 475 |
EXPOSURE DURING PREGNANCY |
323 |
0.0052 |
| 476 |
BODY TEMPERATURE INCREASED |
106 |
0.0052 |
| 477 |
ARRHYTHMIA |
246 |
0.0052 |
| 478 |
WRONG PRODUCT ADMINISTERED |
35 |
0.0052 |
| 479 |
AORTIC VALVE INCOMPETENCE |
22 |
0.0052 |
| 480 |
ILEUS PARALYTIC |
23 |
0.0051 |
| 481 |
HYDROCEPHALUS |
28 |
0.0051 |
| 482 |
CHROMATURIA |
116 |
0.0051 |
| 483 |
BACTERAEMIA |
60 |
0.0051 |
| 484 |
COLITIS ISCHAEMIC |
34 |
0.0050 |
| 485 |
SCREAMING |
32 |
0.0050 |
| 486 |
PNEUMONIA BACTERIAL |
46 |
0.0050 |
| 487 |
ISCHAEMIA |
23 |
0.0050 |
| 488 |
CAESAREAN SECTION |
58 |
0.0050 |
| 489 |
ATAXIA |
59 |
0.0050 |
| 490 |
ENTEROCOCCAL INFECTION |
24 |
0.0050 |
| 491 |
DIALYSIS |
70 |
0.0049 |
| 492 |
ABSCESS LIMB |
21 |
0.0049 |
| 493 |
HEART RATE DECREASED |
172 |
0.0049 |
| 494 |
EJECTION FRACTION DECREASED |
76 |
0.0049 |
| 495 |
HYPOMAGNESAEMIA |
68 |
0.0049 |
| 496 |
SEPSIS |
539 |
0.0048 |
| 497 |
HYPOKALAEMIA |
223 |
0.0048 |
| 498 |
CLOSTRIDIUM DIFFICILE COLITIS |
51 |
0.0048 |
| 499 |
DIVERTICULUM INTESTINAL |
21 |
0.0048 |
| 500 |
PREMATURE LABOUR |
27 |
0.0048 |
| 501 |
DRUG LEVEL INCREASED |
79 |
0.0048 |
| 502 |
ATRIAL FLUTTER |
38 |
0.0048 |
| 503 |
PHYSICAL DISABILITY |
21 |
0.0047 |
| 504 |
MIOSIS |
38 |
0.0047 |
| 505 |
HEPATIC ENCEPHALOPATHY |
44 |
0.0047 |
| 506 |
LIPASE INCREASED |
36 |
0.0047 |
| 507 |
TOXICITY TO VARIOUS AGENTS |
786 |
0.0047 |
| 508 |
DRUG-INDUCED LIVER INJURY |
146 |
0.0046 |
| 509 |
LIVER INJURY |
114 |
0.0046 |
| 510 |
PULMONARY CONGESTION |
61 |
0.0046 |
| 511 |
RESPIRATORY DISORDER |
137 |
0.0046 |
| 512 |
CONCOMITANT DISEASE AGGRAVATED |
28 |
0.0045 |
| 513 |
EPILEPSY |
138 |
0.0045 |
| 514 |
JAUNDICE |
121 |
0.0045 |
| 515 |
POOR QUALITY DRUG ADMINISTERED |
29 |
0.0045 |
| 516 |
HEPATOMEGALY |
44 |
0.0045 |
| 517 |
ELECTROLYTE IMBALANCE |
52 |
0.0045 |
| 518 |
ATRIAL FIBRILLATION |
435 |
0.0045 |
| 519 |
STAPHYLOCOCCAL SEPSIS |
22 |
0.0045 |
| 520 |
SEDATION |
116 |
0.0044 |
| 521 |
HAEMOLYSIS |
34 |
0.0044 |
| 522 |
HEPATIC FUNCTION ABNORMAL |
164 |
0.0044 |
| 523 |
EYELID OEDEMA |
51 |
0.0044 |
| 524 |
INTESTINAL PERFORATION |
49 |
0.0044 |
| 525 |
ACUTE CORONARY SYNDROME |
36 |
0.0043 |
| 526 |
AGRANULOCYTOSIS |
80 |
0.0043 |
| 527 |
HAEMATEMESIS |
109 |
0.0043 |
| 528 |
ENDOCARDITIS |
22 |
0.0043 |
| 529 |
POLYP |
28 |
0.0043 |
| 530 |
MYOCARDITIS |
49 |
0.0043 |
| 531 |
ANAL ABSCESS |
23 |
0.0043 |
| 532 |
HEPATOTOXICITY |
95 |
0.0043 |
| 533 |
PERIORBITAL SWELLING |
24 |
0.0042 |
| 534 |
UNEVALUABLE EVENT |
320 |
0.0042 |
| 535 |
CARDIOVASCULAR DISORDER |
106 |
0.0042 |
| 536 |
SERUM FERRITIN INCREASED |
22 |
0.0042 |
| 537 |
ABORTION INDUCED |
39 |
0.0041 |
| 538 |
RIGHT VENTRICULAR FAILURE |
29 |
0.0041 |
| 539 |
MUSCLE TWITCHING |
95 |
0.0041 |
| 540 |
RASH PUSTULAR |
30 |
0.0041 |
| 541 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
42 |
0.0041 |
| 542 |
EMPHYSEMA |
41 |
0.0041 |
| 543 |
THROMBOCYTOPENIA |
453 |
0.0040 |
| 544 |
ASCITES |
119 |
0.0040 |
| 545 |
SEIZURE |
465 |
0.0040 |
| 546 |
INCOHERENT |
26 |
0.0040 |
| 547 |
DERMATITIS EXFOLIATIVE |
20 |
0.0040 |
| 548 |
CONVULSION |
228 |
0.0040 |
| 549 |
ENTEROCOLITIS |
23 |
0.0040 |
| 550 |
RESPIRATORY RATE INCREASED |
35 |
0.0039 |
| 551 |
PULMONARY HYPERTENSION |
82 |
0.0039 |
| 552 |
DRUG RESISTANCE |
101 |
0.0039 |
| 553 |
BLOOD CREATININE INCREASED |
256 |
0.0039 |
| 554 |
RESPIRATION ABNORMAL |
27 |
0.0039 |
| 555 |
FLUID OVERLOAD |
57 |
0.0039 |
| 556 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
97 |
0.0039 |
| 557 |
RENAL FAILURE CHRONIC |
30 |
0.0039 |
| 558 |
BLOOD UREA INCREASED |
65 |
0.0039 |
| 559 |
POST-TRAUMATIC STRESS DISORDER |
26 |
0.0039 |
| 560 |
GENERALISED OEDEMA |
48 |
0.0039 |
| 561 |
MEDICATION ERROR |
215 |
0.0039 |
| 562 |
ERYTHEMA MULTIFORME |
36 |
0.0039 |
| 563 |
HEMIPLEGIA |
32 |
0.0038 |
| 564 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
34 |
0.0038 |
| 565 |
MALNUTRITION |
43 |
0.0038 |
| 566 |
END STAGE RENAL DISEASE |
70 |
0.0038 |
| 567 |
ACUTE MYOCARDIAL INFARCTION |
113 |
0.0038 |
| 568 |
MYOPATHY |
33 |
0.0038 |
| 569 |
REBOUND EFFECT |
43 |
0.0038 |
| 570 |
HAEMOLYTIC ANAEMIA |
34 |
0.0038 |
| 571 |
HAEMOPTYSIS |
105 |
0.0038 |
| 572 |
PLEURAL EFFUSION |
229 |
0.0038 |
| 573 |
DISORIENTATION |
149 |
0.0038 |
| 574 |
BRONCHOPULMONARY ASPERGILLOSIS |
29 |
0.0037 |
| 575 |
CHOLECYSTITIS ACUTE |
21 |
0.0037 |
| 576 |
DECUBITUS ULCER |
30 |
0.0037 |
| 577 |
DERMATITIS ALLERGIC |
46 |
0.0037 |
| 578 |
HYPERAESTHESIA |
30 |
0.0036 |
| 579 |
ULCER |
58 |
0.0036 |
| 580 |
CEREBRAL INFARCTION |
89 |
0.0036 |
| 581 |
HYPERCHOLESTEROLAEMIA |
35 |
0.0036 |
| 582 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
80 |
0.0036 |
| 583 |
PALLOR |
98 |
0.0036 |
| 584 |
LIVER FUNCTION TEST INCREASED |
77 |
0.0036 |
| 585 |
CEREBRAL HAEMORRHAGE |
128 |
0.0036 |
| 586 |
CHILLS |
418 |
0.0036 |
| 587 |
OROPHARYNGEAL DISCOMFORT |
32 |
0.0035 |
| 588 |
ESCHERICHIA INFECTION |
29 |
0.0035 |
| 589 |
DIVERTICULUM |
25 |
0.0035 |
| 590 |
ARTERIOSCLEROSIS |
33 |
0.0035 |
| 591 |
INTERVERTEBRAL DISC DEGENERATION |
32 |
0.0035 |
| 592 |
LARGE INTESTINE PERFORATION |
24 |
0.0035 |
| 593 |
DRUG ERUPTION |
61 |
0.0034 |
| 594 |
PSYCHOMOTOR HYPERACTIVITY |
57 |
0.0034 |
| 595 |
LIVER FUNCTION TEST ABNORMAL |
99 |
0.0034 |
| 596 |
HYPERGLYCAEMIA |
124 |
0.0034 |
| 597 |
HAEMATURIA |
116 |
0.0034 |
| 598 |
TUBULOINTERSTITIAL NEPHRITIS |
63 |
0.0034 |
| 599 |
LIVE BIRTH |
28 |
0.0033 |
| 600 |
ANAL INCONTINENCE |
30 |
0.0033 |
| 601 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
25 |
0.0033 |
| 602 |
HYPOCALCAEMIA |
63 |
0.0033 |
| 603 |
APHASIA |
100 |
0.0033 |
| 604 |
RENAL CYST |
26 |
0.0033 |
| 605 |
EXTRAPYRAMIDAL DISORDER |
81 |
0.0033 |
| 606 |
SENSORY LOSS |
26 |
0.0032 |
| 607 |
PANCREATITIS |
170 |
0.0032 |
| 608 |
TUMOUR LYSIS SYNDROME |
28 |
0.0032 |
| 609 |
HEPATIC STEATOSIS |
59 |
0.0032 |
| 610 |
THERAPY NON-RESPONDER |
142 |
0.0032 |
| 611 |
RESTLESSNESS |
115 |
0.0031 |
| 612 |
RASH ERYTHEMATOUS |
150 |
0.0031 |
| 613 |
ADRENAL INSUFFICIENCY |
38 |
0.0031 |
| 614 |
QUALITY OF LIFE DECREASED |
42 |
0.0031 |
| 615 |
POISONING |
39 |
0.0031 |
| 616 |
RASH GENERALISED |
80 |
0.0031 |
| 617 |
HIATUS HERNIA |
40 |
0.0031 |
| 618 |
SWOLLEN TONGUE |
96 |
0.0031 |
| 619 |
HEMIPARESIS |
52 |
0.0031 |
| 620 |
POISONING DELIBERATE |
29 |
0.0031 |
| 621 |
CYTOKINE RELEASE SYNDROME |
61 |
0.0030 |
| 622 |
LYMPHOPENIA |
43 |
0.0030 |
| 623 |
CARDIAC FAILURE |
243 |
0.0030 |
| 624 |
CHOLECYSTITIS CHRONIC |
20 |
0.0030 |
| 625 |
BLINDNESS TRANSIENT |
22 |
0.0030 |
| 626 |
URTICARIA |
497 |
0.0030 |
| 627 |
PYREXIA |
1024 |
0.0030 |
| 628 |
NERVOUS SYSTEM DISORDER |
92 |
0.0029 |
| 629 |
MUSCLE SPASTICITY |
36 |
0.0029 |
| 630 |
HICCUPS |
24 |
0.0029 |
| 631 |
POLYNEUROPATHY |
35 |
0.0029 |
| 632 |
WRONG DRUG ADMINISTERED |
26 |
0.0029 |
| 633 |
DYSARTHRIA |
108 |
0.0029 |
| 634 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
49 |
0.0029 |
| 635 |
BLOOD PRESSURE DIASTOLIC DECREASED |
21 |
0.0028 |
| 636 |
ERYTHEMA |
584 |
0.0028 |
| 637 |
INCONTINENCE |
30 |
0.0028 |
| 638 |
COGNITIVE DISORDER |
132 |
0.0028 |
| 639 |
HAEMATOMA |
73 |
0.0028 |
| 640 |
NEPHROPATHY TOXIC |
31 |
0.0028 |
| 641 |
ABSCESS |
44 |
0.0028 |
| 642 |
LOSS OF CONSCIOUSNESS |
350 |
0.0027 |
| 643 |
ACCIDENTAL OVERDOSE |
99 |
0.0027 |
| 644 |
HEART RATE INCREASED |
268 |
0.0027 |
| 645 |
EMOTIONAL DISTRESS |
327 |
0.0027 |
| 646 |
HYPERTENSION |
570 |
0.0027 |
| 647 |
NEPHROPATHY |
25 |
0.0027 |
| 648 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
45 |
0.0027 |
| 649 |
HYPERCALCAEMIA |
33 |
0.0027 |
| 650 |
PROCEDURAL PAIN |
74 |
0.0027 |
| 651 |
SKIN LACERATION |
29 |
0.0027 |
| 652 |
WHITE BLOOD CELL COUNT INCREASED |
102 |
0.0027 |
| 653 |
HAEMATOCRIT DECREASED |
52 |
0.0026 |
| 654 |
BLOOD DISORDER |
21 |
0.0026 |
| 655 |
HYPOKINESIA |
38 |
0.0026 |
| 656 |
WHEEZING |
155 |
0.0026 |
| 657 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
117 |
0.0026 |
| 658 |
NERVE INJURY |
29 |
0.0026 |
| 659 |
MUSCLE ATROPHY |
33 |
0.0026 |
| 660 |
UROSEPSIS |
24 |
0.0026 |
| 661 |
URINARY INCONTINENCE |
77 |
0.0026 |
| 662 |
AGGRESSION |
130 |
0.0026 |
| 663 |
SUBSTANCE ABUSE |
21 |
0.0026 |
| 664 |
URINARY RETENTION |
86 |
0.0026 |
| 665 |
CONTRAINDICATED PRODUCT ADMINISTERED |
78 |
0.0026 |
| 666 |
INTENTIONAL OVERDOSE |
165 |
0.0026 |
| 667 |
HEPATIC CIRRHOSIS |
48 |
0.0026 |
| 668 |
HAEMORRHAGE INTRACRANIAL |
38 |
0.0025 |
| 669 |
INTERNATIONAL NORMALISED RATIO INCREASED |
72 |
0.0025 |
| 670 |
STAPHYLOCOCCAL INFECTION |
83 |
0.0025 |
| 671 |
HAEMORRHOIDS |
49 |
0.0025 |
| 672 |
DRUG EFFECT DECREASED |
135 |
0.0025 |
| 673 |
AKATHISIA |
34 |
0.0025 |
| 674 |
COMPLETED SUICIDE |
207 |
0.0025 |
| 675 |
SECRETION DISCHARGE |
31 |
0.0025 |
| 676 |
WOUND INFECTION |
27 |
0.0025 |
| 677 |
DEEP VEIN THROMBOSIS |
160 |
0.0025 |
| 678 |
BLOOD PRESSURE SYSTOLIC INCREASED |
48 |
0.0025 |
| 679 |
MOVEMENT DISORDER |
79 |
0.0025 |
| 680 |
GLOMERULAR FILTRATION RATE DECREASED |
30 |
0.0024 |
| 681 |
PRODUCT USE IN UNAPPROVED INDICATION |
605 |
0.0024 |
| 682 |
OVERDOSE |
525 |
0.0024 |
| 683 |
C-REACTIVE PROTEIN INCREASED |
88 |
0.0024 |
| 684 |
LIVER DISORDER |
107 |
0.0024 |
| 685 |
PULMONARY EMBOLISM |
228 |
0.0024 |
| 686 |
PETECHIAE |
25 |
0.0024 |
| 687 |
LIP SWELLING |
79 |
0.0024 |
| 688 |
PARKINSONISM |
23 |
0.0024 |
| 689 |
SLEEP APNOEA SYNDROME |
45 |
0.0024 |
| 690 |
GASTROINTESTINAL HAEMORRHAGE |
196 |
0.0023 |
| 691 |
SUICIDE ATTEMPT |
142 |
0.0023 |
| 692 |
OEDEMA |
127 |
0.0023 |
| 693 |
ADVERSE REACTION |
31 |
0.0023 |
| 694 |
CHOLECYSTITIS |
27 |
0.0023 |
| 695 |
CONFUSIONAL STATE |
366 |
0.0023 |
| 696 |
NEUTROPHIL COUNT INCREASED |
23 |
0.0022 |
| 697 |
CORONARY ARTERY DISEASE |
68 |
0.0022 |
| 698 |
HAEMORRHAGE |
234 |
0.0022 |
| 699 |
SUBDURAL HAEMATOMA |
32 |
0.0022 |
| 700 |
DRUG ABUSE |
184 |
0.0022 |
| 701 |
HYPONATRAEMIA |
124 |
0.0022 |
| 702 |
SOPOR |
29 |
0.0022 |
| 703 |
DRUG INEFFECTIVE |
2858 |
0.0022 |
| 704 |
PERICARDIAL EFFUSION |
50 |
0.0022 |
| 705 |
DRUG LEVEL DECREASED |
22 |
0.0022 |
| 706 |
SPLENOMEGALY |
25 |
0.0021 |
| 707 |
ISCHAEMIC STROKE |
38 |
0.0021 |
| 708 |
TRANSFUSION |
22 |
0.0021 |
| 709 |
CONDITION AGGRAVATED |
633 |
0.0021 |
| 710 |
JOINT DISLOCATION |
22 |
0.0021 |
| 711 |
SOMNOLENCE |
419 |
0.0021 |
| 712 |
DIPLOPIA |
54 |
0.0021 |
| 713 |
PANCYTOPENIA |
116 |
0.0021 |
| 714 |
PSYCHOTIC DISORDER |
61 |
0.0021 |
| 715 |
CHRONIC KIDNEY DISEASE |
155 |
0.0020 |
| 716 |
LEUKOPENIA |
101 |
0.0020 |
| 717 |
CYST |
25 |
0.0020 |
| 718 |
WITHDRAWAL SYNDROME |
84 |
0.0020 |
| 719 |
GASTRIC ULCER |
38 |
0.0020 |
| 720 |
OFF LABEL USE |
1736 |
0.0020 |
| 721 |
DYSPHAGIA |
187 |
0.0020 |
| 722 |
OSTEOARTHRITIS |
83 |
0.0020 |
| 723 |
SPEECH DISORDER |
102 |
0.0019 |
| 724 |
MENTAL IMPAIRMENT |
47 |
0.0019 |
| 725 |
BLOOD PRESSURE FLUCTUATION |
46 |
0.0019 |
| 726 |
GENERAL PHYSICAL HEALTH DETERIORATION |
221 |
0.0019 |
| 727 |
MELAENA |
42 |
0.0019 |
| 728 |
CHOLELITHIASIS |
62 |
0.0019 |
| 729 |
DEVICE RELATED INFECTION |
29 |
0.0019 |
| 730 |
DISABILITY |
37 |
0.0019 |
| 731 |
HYPERHIDROSIS |
241 |
0.0019 |
| 732 |
HYPERSENSITIVITY |
346 |
0.0019 |
| 733 |
BLOOD POTASSIUM DECREASED |
56 |
0.0019 |
| 734 |
ANXIETY |
530 |
0.0019 |
| 735 |
HAEMOGLOBIN DECREASED |
190 |
0.0018 |
| 736 |
PLATELET COUNT INCREASED |
24 |
0.0018 |
| 737 |
PHARYNGEAL OEDEMA |
28 |
0.0018 |
| 738 |
INTERSTITIAL LUNG DISEASE |
88 |
0.0018 |
| 739 |
MUSCULAR WEAKNESS |
206 |
0.0018 |
| 740 |
HYPERTHYROIDISM |
26 |
0.0018 |
| 741 |
SPINAL PAIN |
21 |
0.0018 |
| 742 |
PNEUMONIA |
580 |
0.0018 |
| 743 |
ECONOMIC PROBLEM |
27 |
0.0018 |
| 744 |
ANAEMIA |
339 |
0.0018 |
| 745 |
SKIN REACTION |
25 |
0.0018 |
| 746 |
HYPOGLYCAEMIA |
86 |
0.0018 |
| 747 |
MANIA |
29 |
0.0018 |
| 748 |
TREATMENT FAILURE |
146 |
0.0018 |
| 749 |
IMPAIRED GASTRIC EMPTYING |
24 |
0.0018 |
| 750 |
HEPATIC ENZYME INCREASED |
120 |
0.0018 |
| 751 |
PROTEINURIA |
33 |
0.0017 |
| 752 |
RETCHING |
37 |
0.0017 |
| 753 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
63 |
0.0017 |
| 754 |
DRUG ADMINISTRATION ERROR |
53 |
0.0017 |
| 755 |
SMALL INTESTINAL OBSTRUCTION |
21 |
0.0017 |
| 756 |
HALLUCINATION, VISUAL |
36 |
0.0017 |
| 757 |
LYMPHOCYTE COUNT DECREASED |
30 |
0.0017 |
| 758 |
PERITONITIS |
35 |
0.0017 |
| 759 |
SENSORY DISTURBANCE |
27 |
0.0017 |
| 760 |
ABDOMINAL DISTENSION |
175 |
0.0017 |
| 761 |
DRUG EXPOSURE DURING PREGNANCY |
57 |
0.0017 |
| 762 |
GASTRITIS |
44 |
0.0017 |
| 763 |
BACTERIAL INFECTION |
31 |
0.0017 |
| 764 |
BLOOD PRESSURE INCREASED |
254 |
0.0017 |
| 765 |
RASH |
722 |
0.0017 |
| 766 |
DRUG WITHDRAWAL SYNDROME |
145 |
0.0017 |
| 767 |
HYPOTHYROIDISM |
52 |
0.0016 |
| 768 |
DIVERTICULITIS |
45 |
0.0016 |
| 769 |
FLUSHING |
163 |
0.0016 |
| 770 |
PRODUCT ADMINISTRATION ERROR |
32 |
0.0016 |
| 771 |
FEBRILE NEUTROPENIA |
105 |
0.0016 |
| 772 |
PNEUMONITIS |
43 |
0.0016 |
| 773 |
RASH MACULAR |
55 |
0.0016 |
| 774 |
RASH PAPULAR |
35 |
0.0016 |
| 775 |
DRUG EFFECT LESS THAN EXPECTED |
23 |
0.0016 |
| 776 |
SWELLING FACE |
101 |
0.0015 |
| 777 |
PRESCRIBED OVERDOSE |
30 |
0.0015 |
| 778 |
CELLULITIS |
78 |
0.0015 |
| 779 |
RESTLESS LEGS SYNDROME |
28 |
0.0015 |
| 780 |
SNEEZING |
34 |
0.0015 |
| 781 |
PLATELET COUNT DECREASED |
161 |
0.0015 |
| 782 |
AMNESIA |
98 |
0.0015 |
| 783 |
COORDINATION ABNORMAL |
21 |
0.0015 |
| 784 |
VOMITING |
704 |
0.0015 |
| 785 |
MUSCLE TIGHTNESS |
24 |
0.0015 |
| 786 |
INFLAMMATION |
76 |
0.0015 |
| 787 |
CLOSTRIDIUM DIFFICILE INFECTION |
32 |
0.0015 |
| 788 |
SCAR |
25 |
0.0015 |
| 789 |
OSTEOPENIA |
22 |
0.0014 |
| 790 |
LUNG DISORDER |
71 |
0.0014 |
| 791 |
TREMOR |
238 |
0.0014 |
| 792 |
TREATMENT NONCOMPLIANCE |
77 |
0.0014 |
| 793 |
IMPAIRED WORK ABILITY |
30 |
0.0014 |
| 794 |
LETHARGY |
80 |
0.0014 |
| 795 |
CONJUNCTIVITIS |
25 |
0.0013 |
| 796 |
COLITIS |
51 |
0.0013 |
| 797 |
HALLUCINATION |
101 |
0.0013 |
| 798 |
EPISTAXIS |
100 |
0.0013 |
| 799 |
DYSURIA |
49 |
0.0013 |
| 800 |
CARDIAC FAILURE CONGESTIVE |
104 |
0.0013 |
| 801 |
BLISTER |
72 |
0.0013 |
| 802 |
GASTROOESOPHAGEAL REFLUX DISEASE |
103 |
0.0013 |
| 803 |
METASTASES TO BONE |
21 |
0.0013 |
| 804 |
BONE MARROW FAILURE |
26 |
0.0013 |
| 805 |
OSTEOMYELITIS |
23 |
0.0013 |
| 806 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
45 |
0.0013 |
| 807 |
MOOD SWINGS |
40 |
0.0013 |
| 808 |
COLD SWEAT |
22 |
0.0012 |
| 809 |
DYSPNOEA EXERTIONAL |
47 |
0.0012 |
| 810 |
CANDIDA INFECTION |
21 |
0.0012 |
| 811 |
OEDEMA PERIPHERAL |
151 |
0.0012 |
| 812 |
ABNORMAL BEHAVIOUR |
49 |
0.0012 |
| 813 |
INTENTIONAL PRODUCT MISUSE |
108 |
0.0012 |
| 814 |
DYSPNOEA |
697 |
0.0012 |
| 815 |
FUNGAL INFECTION |
41 |
0.0012 |
| 816 |
PHOTOPHOBIA |
23 |
0.0012 |
| 817 |
MENTAL DISORDER |
53 |
0.0012 |
| 818 |
PAIN |
747 |
0.0012 |
| 819 |
OSTEONECROSIS OF JAW |
30 |
0.0012 |
| 820 |
BLOOD PRESSURE ABNORMAL |
24 |
0.0012 |
| 821 |
LIMB DISCOMFORT |
37 |
0.0012 |
| 822 |
HEART RATE IRREGULAR |
27 |
0.0012 |
| 823 |
PHARMACEUTICAL PRODUCT COMPLAINT |
31 |
0.0012 |
| 824 |
RECTAL HAEMORRHAGE |
51 |
0.0012 |
| 825 |
LYMPHADENOPATHY |
42 |
0.0012 |
| 826 |
NEUTROPENIA |
161 |
0.0012 |
| 827 |
COUGH |
327 |
0.0012 |
| 828 |
THERAPEUTIC RESPONSE DECREASED |
70 |
0.0012 |
| 829 |
DEAFNESS |
30 |
0.0011 |
| 830 |
SYNCOPE |
114 |
0.0011 |
| 831 |
INFECTION |
164 |
0.0011 |
| 832 |
TINNITUS |
52 |
0.0011 |
| 833 |
DEHYDRATION |
150 |
0.0011 |
| 834 |
PRODUCT QUALITY ISSUE |
152 |
0.0011 |
| 835 |
ABDOMINAL PAIN |
260 |
0.0011 |
| 836 |
BONE DISORDER |
20 |
0.0011 |
| 837 |
FLATULENCE |
62 |
0.0011 |
| 838 |
MYALGIA |
185 |
0.0011 |
| 839 |
MYOCARDIAL INFARCTION |
189 |
0.0011 |
| 840 |
SKIN ULCER |
28 |
0.0011 |
| 841 |
FAECES DISCOLOURED |
23 |
0.0011 |
| 842 |
PAIN IN JAW |
30 |
0.0011 |
| 843 |
RED BLOOD CELL COUNT DECREASED |
30 |
0.0010 |
| 844 |
TRANSIENT ISCHAEMIC ATTACK |
35 |
0.0010 |
| 845 |
CEREBROVASCULAR ACCIDENT |
173 |
0.0010 |
| 846 |
BACK PAIN |
237 |
0.0010 |
| 847 |
DEPRESSION |
232 |
0.0010 |
| 848 |
INTENTIONAL PRODUCT USE ISSUE |
89 |
0.0010 |
| 849 |
CHEST PAIN |
188 |
0.0010 |
| 850 |
RENAL DISORDER |
47 |
0.0010 |
| 851 |
FEELING COLD |
28 |
0.0010 |
| 852 |
OROPHARYNGEAL PAIN |
93 |
0.0010 |
| 853 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
71 |
0.0010 |
| 854 |
CARDIAC DISORDER |
93 |
0.0010 |
| 855 |
ASTHENIA |
366 |
0.0010 |
| 856 |
URINARY TRACT INFECTION |
164 |
0.0010 |
| 857 |
DIABETIC KETOACIDOSIS |
23 |
0.0010 |
| 858 |
SKIN LESION |
26 |
0.0009 |
| 859 |
PRESYNCOPE |
23 |
0.0009 |
| 860 |
DISTURBANCE IN ATTENTION |
51 |
0.0009 |
| 861 |
NEUTROPHIL COUNT DECREASED |
38 |
0.0009 |
| 862 |
THROMBOSIS |
75 |
0.0009 |
| 863 |
WOUND |
26 |
0.0009 |
| 864 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
27 |
0.0009 |
| 865 |
PRODUCTIVE COUGH |
44 |
0.0009 |
| 866 |
SLEEP DISORDER |
65 |
0.0009 |
| 867 |
RASH PRURITIC |
49 |
0.0009 |
| 868 |
DISEASE RECURRENCE |
43 |
0.0009 |
| 869 |
NAUSEA |
713 |
0.0009 |
| 870 |
IRRITABILITY |
54 |
0.0009 |
| 871 |
CHEST DISCOMFORT |
91 |
0.0009 |
| 872 |
DRUG EFFECT INCOMPLETE |
32 |
0.0009 |
| 873 |
DIABETES MELLITUS |
67 |
0.0009 |
| 874 |
PRODUCT USE ISSUE |
165 |
0.0009 |
| 875 |
PARAESTHESIA |
138 |
0.0009 |
| 876 |
EMOTIONAL DISORDER |
27 |
0.0009 |
| 877 |
IMPAIRED HEALING |
28 |
0.0009 |
| 878 |
TARDIVE DYSKINESIA |
24 |
0.0008 |
| 879 |
PANIC ATTACK |
31 |
0.0008 |
| 880 |
SKIN DISCOLOURATION |
39 |
0.0008 |
| 881 |
FEELING HOT |
52 |
0.0008 |
| 882 |
RESPIRATORY TRACT INFECTION |
22 |
0.0008 |
| 883 |
ANGINA PECTORIS |
24 |
0.0008 |
| 884 |
HYPOAESTHESIA |
124 |
0.0008 |
| 885 |
DISCOMFORT |
49 |
0.0008 |
| 886 |
NO ADVERSE EVENT |
144 |
0.0008 |
| 887 |
DYSPHONIA |
46 |
0.0008 |
| 888 |
MEMORY IMPAIRMENT |
108 |
0.0008 |
| 889 |
MUSCULOSKELETAL STIFFNESS |
68 |
0.0008 |
| 890 |
SWELLING |
72 |
0.0008 |
| 891 |
POLLAKIURIA |
32 |
0.0008 |
| 892 |
MOBILITY DECREASED |
53 |
0.0007 |
| 893 |
UPPER RESPIRATORY TRACT INFECTION |
34 |
0.0007 |
| 894 |
NECK PAIN |
41 |
0.0007 |
| 895 |
RHINORRHOEA |
47 |
0.0007 |
| 896 |
INFUSION RELATED REACTION |
48 |
0.0007 |
| 897 |
GAIT DISTURBANCE |
138 |
0.0007 |
| 898 |
SKIN DISORDER |
24 |
0.0007 |
| 899 |
MUSCLE SPASMS |
132 |
0.0007 |
| 900 |
BLINDNESS |
29 |
0.0007 |
| 901 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
37 |
0.0007 |
| 902 |
ASTHMA |
79 |
0.0007 |
| 903 |
HEAD INJURY |
22 |
0.0007 |
| 904 |
PRODUCT SUBSTITUTION ISSUE |
40 |
0.0007 |
| 905 |
CONSTIPATION |
151 |
0.0007 |
| 906 |
HAEMATOCHEZIA |
38 |
0.0007 |
| 907 |
INFLUENZA LIKE ILLNESS |
56 |
0.0007 |
| 908 |
NEPHROLITHIASIS |
31 |
0.0007 |
| 909 |
VAGINAL HAEMORRHAGE |
29 |
0.0007 |
| 910 |
MUSCULOSKELETAL PAIN |
35 |
0.0007 |
| 911 |
CYSTITIS |
21 |
0.0007 |
| 912 |
PALPITATIONS |
76 |
0.0006 |
| 913 |
WHITE BLOOD CELL COUNT DECREASED |
70 |
0.0006 |
| 914 |
PRURITUS |
245 |
0.0006 |
| 915 |
NERVOUSNESS |
33 |
0.0006 |
| 916 |
WEIGHT DECREASED |
176 |
0.0006 |
| 917 |
VISION BLURRED |
85 |
0.0006 |
| 918 |
LOWER RESPIRATORY TRACT INFECTION |
28 |
0.0006 |
| 919 |
DEATH |
530 |
0.0006 |
| 920 |
INTESTINAL OBSTRUCTION |
23 |
0.0006 |
| 921 |
ILL-DEFINED DISORDER |
37 |
0.0006 |
| 922 |
MIGRAINE |
58 |
0.0006 |
| 923 |
DISEASE PROGRESSION |
70 |
0.0006 |
| 924 |
DRUG DEPENDENCE |
95 |
0.0006 |
| 925 |
ABDOMINAL PAIN UPPER |
121 |
0.0006 |
| 926 |
BURNING SENSATION |
41 |
0.0006 |
| 927 |
VISUAL IMPAIRMENT |
72 |
0.0006 |
| 928 |
BRONCHITIS |
43 |
0.0006 |
| 929 |
BALANCE DISORDER |
50 |
0.0006 |
| 930 |
CATARACT |
34 |
0.0006 |
| 931 |
EXTRA DOSE ADMINISTERED |
23 |
0.0006 |
| 932 |
DIZZINESS |
283 |
0.0006 |
| 933 |
INSOMNIA |
151 |
0.0006 |
| 934 |
OSTEOPOROSIS |
23 |
0.0006 |
| 935 |
FLUID RETENTION |
28 |
0.0005 |
| 936 |
HEADACHE |
345 |
0.0005 |
| 937 |
GASTROINTESTINAL DISORDER |
49 |
0.0005 |
| 938 |
NEUROPATHY PERIPHERAL |
52 |
0.0005 |
| 939 |
SURGERY |
32 |
0.0005 |
| 940 |
ARTHROPATHY |
30 |
0.0005 |
| 941 |
THROAT IRRITATION |
24 |
0.0005 |
| 942 |
ROAD TRAFFIC ACCIDENT |
22 |
0.0005 |
| 943 |
DIARRHOEA |
339 |
0.0005 |
| 944 |
VERTIGO |
32 |
0.0005 |
| 945 |
DYSPEPSIA |
51 |
0.0005 |
| 946 |
COVID-19 |
90 |
0.0005 |
| 947 |
HYPOACUSIS |
22 |
0.0005 |
| 948 |
DECREASED APPETITE |
118 |
0.0005 |
| 949 |
PAIN IN EXTREMITY |
149 |
0.0005 |
| 950 |
FALL |
168 |
0.0005 |
| 951 |
ECZEMA |
26 |
0.0005 |
| 952 |
MALAISE |
214 |
0.0005 |
| 953 |
DEVICE DISLOCATION |
21 |
0.0005 |
| 954 |
DRUG INTOLERANCE |
46 |
0.0005 |
| 955 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
22 |
0.0005 |
| 956 |
ADVERSE DRUG REACTION |
41 |
0.0005 |
| 957 |
STOMATITIS |
27 |
0.0004 |
| 958 |
THERAPY CESSATION |
22 |
0.0004 |
| 959 |
CONTUSION |
41 |
0.0004 |
| 960 |
BLOOD GLUCOSE INCREASED |
80 |
0.0004 |
| 961 |
DEVICE ISSUE |
38 |
0.0004 |
| 962 |
INCORRECT DOSE ADMINISTERED |
94 |
0.0004 |
| 963 |
SUICIDAL IDEATION |
37 |
0.0004 |
| 964 |
DYSGEUSIA |
30 |
0.0004 |
| 965 |
SKIN EXFOLIATION |
34 |
0.0004 |
| 966 |
HERPES ZOSTER |
23 |
0.0004 |
| 967 |
INJECTION SITE SWELLING |
30 |
0.0004 |
| 968 |
DRY MOUTH |
31 |
0.0004 |
| 969 |
EYE PAIN |
21 |
0.0004 |
| 970 |
INFLUENZA |
41 |
0.0004 |
| 971 |
PERIPHERAL SWELLING |
55 |
0.0004 |
| 972 |
FATIGUE |
276 |
0.0004 |
| 973 |
RHEUMATOID ARTHRITIS |
39 |
0.0003 |
| 974 |
ADVERSE EVENT |
31 |
0.0003 |
| 975 |
INJECTION SITE REACTION |
23 |
0.0003 |
| 976 |
SINUSITIS |
34 |
0.0003 |
| 977 |
WEIGHT INCREASED |
74 |
0.0003 |
| 978 |
ARTHRALGIA |
136 |
0.0003 |
| 979 |
FEELING ABNORMAL |
78 |
0.0003 |
| 980 |
ABDOMINAL DISCOMFORT |
53 |
0.0003 |
| 981 |
UNDERDOSE |
23 |
0.0003 |
| 982 |
DEVICE MALFUNCTION |
22 |
0.0003 |
| 983 |
MALIGNANT NEOPLASM PROGRESSION |
29 |
0.0003 |
| 984 |
ARTHRITIS |
21 |
0.0003 |
| 985 |
ACCIDENTAL EXPOSURE TO PRODUCT |
27 |
0.0003 |
| 986 |
JOINT SWELLING |
26 |
0.0002 |
| 987 |
NASOPHARYNGITIS |
36 |
0.0002 |
| 988 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
38 |
0.0002 |
| 989 |
ALOPECIA |
35 |
0.0002 |
| 990 |
INJECTION SITE ERYTHEMA |
21 |
0.0002 |
| 991 |
PRODUCT DOSE OMISSION ISSUE |
48 |
0.0002 |
| 992 |
HOSPITALISATION |
25 |
0.0002 |
| 993 |
INJECTION SITE PAIN |
44 |
0.0001 |
| 994 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
25 |
0.0001 |